000250.KQ · Korea · Healthcare
As of July 21, 2026 at 10:31 AM KST, 삼천당제약 (000250.KQ) has a market cap of $4B (≈ ₩5.6T) — #295 worldwide on this unified board of 300 major Korean, US, and Japanese stocks, and #95 among Korea names.
Compared with global #1 NVIDIA Corporation ($4.92T), that is 0.1% — it would take 1299.0× 삼천당제약 to match one NVIDIA Corporation. The gap to #294 원익IPS ($4B) right above is $29M. Right below at #296 is 삼성카드 ($4B).
Within the Healthcare sector it ranks #26 of 26; the sector leader is Eli Lilly and Company (global #12). The stock trades at $161.59, with roughly 23M shares outstanding (estimated).
삼천당제약 (000250.KQ) has a market cap of about $4B. Figures refresh hourly with prices and exchange rates.
Across 300 major Korean, US, and Japanese stocks compared on one KRW-converted board, 삼천당제약 ranks #295 worldwide and #95 among Korea stocks.
삼천당제약 is at 0.1% of global #1 NVIDIA Corporation ($4.92T) — a gap of about $4.92T.